NCAPD3 and neoplasm: NCAPD3 was highly expressed in PTC tissues and correlated with aggressive clinicopathological features (e.g., tumor size and lymphovascular invasion), and NCAPD3 silencing inhibited proliferation, migration, invasion, and aerobic glycolysis of PTC cells.